세계의 핵산 분리 및 정제 시장 규모, 점유율, 산업 동향 분석 보고서 : 용도별, 제품별, 방법별, 유형별, 최종 사용자별, 지역별 전망 및 예측(2023-2030년)

The Global Nucleic Acid Isolation and Purification Market size is expected to reach $11.5 billion by 2030, rising at a market growth of 9.2% CAGR during the forecast period.

Circulating nucleic acid isolation and purification are crucial in liquid biopsy techniques, offering non-invasive methods for monitoring diseases, especially cancer. Therefore, the circulating nucleic acid isolation and purification segment captured $862.2 million revenue in the market in 2022. The ability to isolate and purify cfDNA or circRNA from blood samples allows for the detection and monitoring of tumor-related mutations, aiding in early diagnosis, treatment monitoring, and prognostic assessment.

The major strategies followed by the market participants are Product Launches as the key developmental strategy to keep pace with the changing demands of end users. For instance, in October, 2023, Bio-Rad Laboratories, Inc. released two products, PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, to enhance their product portfolio of PCR thermal cyclers. The new products help support PCR applications in process development and in basic and translational research. In September, 2023, Qiagen N.V introduced two products, the QIAwave RNeasy Plus Mini Kit and the QIAwave DNA/RNA Mini Kit, to enhance its QIAwave product portfolio. The new products are more sustainable than the standard kits from Qiagen and offer high-quality performance.

Based on the Analysis presented in the KBV Cardinal matrix; F. Hoffmann-La Roche Ltd. is the forerunner in the market. In February, 2022, F. Hoffmann-La Roche Ltd. introduced the COVID-19 PCR tests like the cobas SARS-CoV-2 Qualitative and the cobas SARS-CoV-2 and Influenza A/B tests to the cobas 5800 System, a molecular laboratory instrument. The new products help to enhance the molecular product portfolio of Roche Diagnostics and offer better performance and strategies for the laboratory testing needs of all volumes. Companies such as Thermo Fisher Scientific, Inc., Danaher Corporation, Merck KGaA are some of the key innovators in market.

Market Growth Factors

Increasing R&D in Genomics, Molecular Biology, and Personalized Medicine

Genomics involves the study of an organism's complete DNA sequence and how it functions. With the advent of high-throughput sequencing technologies (next-generation sequencing - NGS), there's been a massive surge in genomics research. These are essential steps in sequencing and analyzing the vast amounts of genetic data obtained, thus driving the need for efficient and reliable isolation and purification techniques. Furthermore, customized medicine entails adapting medical therapy to each patient's unique traits. This includes utilizing an individual's genetic information to select the most suitable treatment. Nucleic acid isolation and purification are fundamental steps in extracting and analyzing an individual's genetic material, enabling the development of targeted therapies, diagnostics, and treatment plans. These factors will drive the growth in the market.

Ongoing Technological Improvements

Modern technologies have streamlined these processes, reducing manual intervention and human error. Automated systems, magnetic bead-based methods, and silica membrane-based purification have significantly improved efficiency, enabling higher throughput and faster processing of samples. Advanced methodologies, such as rapid kits and automated systems, have drastically reduced the time required for nucleic acid isolation and purification. Furthermore, the miniaturization of devices and the development of high-throughput platforms allow the simultaneous processing of multiple samples, significantly increasing the throughput capacity while maintaining quality and precision. Integrating nucleic acid isolation and purification techniques with other technologies, such as sequencing, PCR, microarray analysis, and CRISPR-based applications, has streamlined workflows, providing a seamless transition between various steps in these processes. These aspects will help accelerate the growth of the market.

Market Restraining Factors

High Initial Investments

Smaller laboratories or research facilities with limited budgets may find it challenging to allocate a significant portion of their funds to purchase high-quality equipment. Due to budget constraints, some smaller laboratories may be unable to afford the latest and most efficient technologies. This can limit the quality and quantity of their research, potentially hampering their competitiveness and ability to secure research grants or collaborations. In addition to the initial investment, ongoing operational costs for consumables, maintenance, and skilled personnel can be substantial. Smaller labs with budget constraints may struggle to maintain these systems efficiently, leading to lower quality and throughput. Smaller laboratories may find it challenging to keep up with these innovations as they lack the resources to invest in new equipment and training. These factors will limit the growth in the market.

Application Outlook

Based on application, the market is divided into diagnostics, drug discovery & development, personalized medicine, agriculture & animal research, and others. The diagnostics segment recorded the maximum revenue share in the market in 2022. Molecular diagnostic tests, which rely on this, are increasingly being used for disease detection, monitoring, and treatment decisions. This includes applications in infectious disease testing, cancer diagnostics, genetic testing, and other areas. Ongoing technological advancements in these methods have made these processes more efficient, accurate, and faster.

Product Outlook

Based on product, the market is segmented into kits, reagents, and instruments. In 2022, the instruments segment garnered a significant revenue share in the market. The demand for automated systems that can handle high sample volumes efficiently has significantly boosted the growth of instruments in this sector. These systems streamline this process, reducing human intervention and minimizing the chances of errors. Innovations in instrument design and functionality have played a crucial role in the market's growth.

Method Outlook

On the basis of method, the market is divided into column based, magnetic beads, reagent based, and others. In 2022, the magnetic beads segment witnessed the maximum revenue share in the market. Magnetic bead-based isolation methods offer high efficiency in capturing nucleic acids from samples. These beads are functionalized with coatings that specifically bind nucleic acids, enabling highly selective extraction resulting in pure yields of DNA or RNA. The magnetic bead-based methods are highly amenable to automation and high-throughput processing, making them ideal for handling large volumes of samples simultaneously.

Type Outlook

By type, the market is divided into plasmid DNA isolation & purification, total RNA isolation & purification, circulating nucleic acid isolation & purification, genomic DNA isolation & purification, messenger RNA isolation & purification, microRNA isolation & purification, and others. In 2022, the total RNA isolation and purification segment witnessed a promising revenue share in the market. The growing emphasis on understanding gene expression and regulation in molecular biology has driven the demand for high-quality RNA. Researchers require pure RNA samples for various applications, including gene expression studies, RNA sequencing, microarray analysis, and other molecular biology techniques. Thus, the segment will proliferate in the upcoming years.

End User Outlook

On the basis of end user, the market is segmented into hospitals & diagnostic centres, academic research institutes, pharmaceutical & biotechnology companies, contract research organizations, and others. The hospitals and diagnostic centres segment held the largest revenue share in the market in 2022. Hospitals and diagnostic centres are increasingly incorporating molecular diagnostics into their services. This involves using these techniques to identify pathogens, genetic disorders, and various diseases. These facilities are adopting advanced technologies to provide accurate and quick diagnostic results.

Regional Outlook

By region, the market is segmented into North America, Europe, Asia Pacific, and LAMEA. The North America segment procured the highest revenue share in the market in 2022. North America is a hub for technological innovation in the life sciences and biotechnology sectors. Significant investments in research and development have led to the continuous evolution of these techniques. Advanced methods, automation, and high-throughput technologies are being developed and adopted, enhancing the efficiency and precision of these processes.

The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.

Nucleic Acid Isolation and Purification Market Report Coverage:

Report Attribute Details

Market size value in 2022 USD 5.8 Billion

Market size forecast in 2030 USD 11.5 Billion

Base Year 2022

Historical period 2019 to 2021

Forecast Period 2023 to 2030

Revenue Growth Rate CAGR of 9.2% from 2023 to 2030

Number of Pages 439

Tables 613

Report Coverage Market Trends, Revenue Estimation and Forecast, Segmentation Analysis, Regional and Country Breakdown, Competitive Landscape, Market Share Analysis, Porter's 5 Forces Analysis, Company Profiling, Companies Strategic Developments, SWOT Analysis, Winning Imperatives

Segments Covered Type, Product, Method, Application, End User, Region

Country Scope * North America (US, Canada, Mexico, and Rest of North America)

• Europe (Germany, UK, France, Russia, Spain, Italy, and Rest of Europe)
• Asia Pacific (China, Japan, India, South Korea, Singapore, Malaysia, and Rest of Asia Pacific)
• LAMEA (Brazil, Argentina, UAE, Saudi Arabia, South Africa, Nigeria, and Rest of LAMEA)

Companies Included Thermo Fisher Scientific, Inc., Qiagen N.V., F. Hoffmann-La Roche Ltd., Merck KGaA, Promega Corporation, Agilent Technologies, Inc., Danaher Corporation, Bio-Rad laboratories, Inc., Illumina, Inc., and New England Biolabs, Inc.

Growth Drivers * Increasing R&D in Genomics, Molecular Biology, and Personalized Medicine

* Ongoing Technological Improvements

Restraints * High Initial Investments

Recent Strategies Deployed in Nucleic Acid Isolation and Purification Market

Partnerships, Collaborations, and Agreements:

Jul-2023: Promega Corporation entered into an agreement with INOVIQ Limited, an Australian company in the biotechnology industry. Under this agreement, the companies marketed the EXO-NET exosome capture technology of INOVIQ and the Nucleic Acid purification systems of Promega globally. Additionally, the companies provided the customers with a wide range of products by incorporating the Promega manual and automated nucleic acid extraction reagents with the EXO-NET exosome capture tools of INOVIQ.

Apr-2020: Thermo Fisher Scientific, Inc. formed a partnership with Hamilton Company, a manufacturer of automated liquid handling and sample management. Under this partnership, the ID NIMBUS Presto workstation was introduced. The ID NIMBUS Presto workstation helps in decreasing the time of sample preparation and offers high-quality nucleic acid purification.

Jan-2020: F. Hoffmann-La Roche Ltd. came into an agreement with Illumina, Inc., an American biotechnology company. Under this agreement, the companies strengthened the worldwide adoption of NGS in cancer care. Additionally, Roche received the rights to develop the in-vitro diagnostic (IVD) tests on the NextSeq 550Dx System of Illumina.

Product Launches and Product Expansions:

Oct-2023: Bio-Rad Laboratories, Inc. released two products, PTC Tempo 48/48 and PTC Tempo 384 Thermal Cyclers, to enhance their product portfolio of PCR thermal cyclers. The new products help support PCR applications in process development and in basic and translational research. Additionally, the PTC Tempo Thermal Cyclers have the features of flexible connectivity and an intuitive user interface, which assist in regulating protocol management.

Sep-2023: Qiagen N.V introduced two products, the QIAwave RNeasy Plus Mini Kit and the QIAwave DNA/RNA Mini Kit, to enhance its QIAwave product portfolio. The new products are more sustainable than the standard kits from Qiagen and offer high-quality performance. Additionally, the new product increases the eco-friendly product options of the company and provides scientific advancement without causing environmental degradation.

Jan-2023: Qiagen N.V launched the EZ2 Connect MDx, which can be used in laboratories. The EZ2 Connect MDx performs the purification of DNA and RNA from 24 samples simultaneously over a time period of 30 minutes.

Feb-2022: F. Hoffmann-La Roche Ltd. introduced the COVID-19 PCR tests like the cobas SARS-CoV-2 Qualitative and the cobas SARS-CoV-2 and Influenza A/B tests to the cobas 5800 System, a molecular laboratory instrument. The new products help to enhance the molecular product portfolio of Roche Diagnostics and offer better performance and strategies for the laboratory testing needs of all volumes. Additionally, the new product assists healthcare systems with limited spaces and resources.

Dec-2021: F. Hoffmann-La Roche Ltd. introduced infectious disease tests like cobas HIV-1, cobas HCV, cobas HBV, cobas HIV-1/HIV-2 Qualitative, and the cobas omni-Utility Channel kit to the cobas 5800 System, which is a molecular laboratory instrument. The new products help to enhance the molecular product portfolio of Roche by providing organized efficiencies and performances for molecular laboratory requirements of various volumes.

Oct-2021: Thermo Fisher Scientific, Inc. unveiled the MagMAX Wastewater Ultra Nucleic Acid Isolation Kit, a testing method to determine infection rates about two weeks earlier than other pooled and individual testing. The MagMAX Wastewater Ultra Nucleic Acid Isolation Kit offers solutions for conveniently implementing surveillance programs and installing SARS-CoV-2 testing methods in both existing and newly constructed labs.

Mar-2021: Promega Corporation launched the XpressAmp Direct Amplification Reagents, which enable automated sample preparation through a method without the involvement of RNA extraction. The XpressAmp Direct Amplification Reagents assist COVID-19 testing laboratories to eliminate the RNA extraction procedures and directly shift to conducting the polymerase chain reaction (PCR).

Acquisition and Mergers:

Jan-2023: Qiagen N.V. took over Verogen, Inc., a developer of DNA-based biometric human identification products for analysis of forensic genomic samples. Through this acquisition, both companies provided unique solutions to improve investigations and research to advance forensic science, find missing persons, and identify suspects accurately.

May-2022: Qiagen N.V completed the acquisition of BLIRT S.A., a European manufacturer of recombinant enzymes for the life science industry. Through this acquisition, Qiagen enhanced its capabilities and strengthened its reagents and enzyme businesses.

Apr-2020: Bio-Rad Laboratories, Inc. took over Celsee, Inc., a company offering instruments for analyzing single cells. Through this acquisition, Bio-Rad Laboratories utilized the Genesis System of Celsee to gather cell-based information and interpret cellular behaviour to get better results. Additionally, the acquisition helped to monitor tumor cell circulation and find out the disease progression and the required therapeutic response.

Scope of the Study

Market Segments covered in the Report:

By Application

• Diagnostics
• Drug Discovery & Development
• Agriculture & Animal Research
• Personalized Medicine & Others

By Product

• Reagents
• Kits
• Instruments

By Method

• Magnetic Beads
• Column Based
• Reagent Based
• Others

By Type

• Plasmid DNA Isolation & Purification
• Total RNA Isolation & Purification
• Circulating Nucleic Acid Isolation & Purification
• Genomic DNA Isolation & Purification
• Messenger RNA Isolation & Purification
• microRNA Isolation & Purification
• Others

By End User

• Hospitals & Diagnostic Centers
• Pharmaceutical & Biotechnology Companies
• Academic Research Institutes
• Contract Research Organizations
• Others

By Geography

• North America
  • US
  • Canada
  • Mexico
  • Rest of North America
• Europe
  • Germany
  • UK
  • France
  • Russia
  • Spain
  • Italy
  • Rest of Europe
• Asia Pacific
  • China
  • Japan
  • India
  • South Korea
  • Singapore
  • Malaysia
  • Rest of Asia Pacific
• LAMEA
  • Brazil
  • Argentina
  • UAE
  • Saudi Arabia
  • South Africa
  • Nigeria
  • Rest of LAMEA

Companies Profiled

• Thermo Fisher Scientific, Inc.
• Qiagen N.V.
• F. Hoffmann-La Roche Ltd.
• Merck KGaA
• Promega Corporation
• Agilent Technologies, Inc.
• Danaher Corporation
• Bio-Rad laboratories, Inc.
• Illumina, Inc.
• New England Biolabs, Inc.

Unique Offerings from KBV Research

• Exhaustive coverage
• Highest number of market tables and figures
• Subscription based model available
• Guaranteed best price
• Assured post sales research support with 10% customization free

Table of Contents

Chapter 1. Market Scope & Methodology

• 1.1 Market Definition
• 1.2 Objectives
• 1.3 Market Scope
• 1.4 Segmentation
  • 1.4.1 Global Nucleic Acid Isolation and Purification Market, by Application
  • 1.4.2 Global Nucleic Acid Isolation and Purification Market, by Product
  • 1.4.3 Global Nucleic Acid Isolation and Purification Market, by Method
  • 1.4.4 Global Nucleic Acid Isolation and Purification Market, by Type
  • 1.4.5 Global Nucleic Acid Isolation and Purification Market, by End User
  • 1.4.6 Global Nucleic Acid Isolation and Purification Market, by Geography
• 1.5 Methodology for the research

Chapter 2. Market At a Glance

• 2.1 Key Highlights

Chapter 3. Market Overview

• 3.1 Introduction
  • 3.1.1 Overview
    • 3.1.1.1 Market Composition and Scenario
• 3.2 Key Factors Impacting the Market
  • 3.2.1 Market Drivers
  • 3.2.2 Market Restraints

Chapter 4. Competition Analysis - Global

• 4.1 KBV Cardinal Matrix
• 4.2 Recent Industry Wide Strategic Developments
  • 4.2.1 Partnerships, Collaborations and Agreements
  • 4.2.2 Product Launches and Product Expansions
  • 4.2.3 Acquisition and Mergers
• 4.3 Market Share Analysis, 2022
• 4.4 Top Winning Strategies
  • 4.4.1 Key Leading Strategies: Percentage Distribution (2019-2023)
  • 4.4.2 Key Strategic Move: (Product Launches and Product Expansions: 2021, Mar - 2023, Oct) Leading Players
• 4.5 Porter's Five Forces Analysis

Chapter 5. Global Nucleic Acid Isolation and Purification Market by Application

• 5.1 Global Diagnostics Market by Region
• 5.2 Global Drug Discovery & Development Market by Region
• 5.3 Global Agriculture & Animal Research Market by Region
• 5.4 Global Personalized Medicine & Others Market by Region

Chapter 6. Global Nucleic Acid Isolation and Purification Market by Product

• 6.1 Global Reagents Market by Region
• 6.2 Global Kits Market by Region
• 6.3 Global Instruments Market by Region

Chapter 7. Global Nucleic Acid Isolation and Purification Market by Method

• 7.1 Global Magnetic Beads Market by Region
• 7.2 Global Column Based Market by Region
• 7.3 Global Reagent Based Market by Region
• 7.4 Global Others Market by Region

Chapter 8. Global Nucleic Acid Isolation and Purification Market by Type

• 8.1 Global Plasmid DNA Isolation & Purification Market by Region
• 8.2 Global Total RNA Isolation & Purification Market by Region
• 8.3 Global Circulating Nucleic Acid Isolation & Purification Market by Region
• 8.4 Global Genomic DNA Isolation & Purification Market by Region
• 8.5 Global Messenger RNA Isolation & Purification Market by Region
• 8.6 Global microRNA Isolation & Purification Market by Region
• 8.7 Global Others Market by Region

Chapter 9. Global Nucleic Acid Isolation and Purification Market by End User

• 9.1 Global Hospitals & Diagnostic Centers Market by Region
• 9.2 Global Pharmaceutical & Biotechnology Companies Market by Region
• 9.3 Global Academic Research Institutes Market by Region
• 9.4 Global Contract Research Organizations Market by Region
• 9.5 Global Others Market by Region

Chapter 10. Global Nucleic Acid Isolation and Purification Market by Region

• 10.1 North America Nucleic Acid Isolation and Purification Market
  • 10.1.1 North America Nucleic Acid Isolation and Purification Market by Application
    • 10.1.1.1 North America Diagnostics Market by Country
    • 10.1.1.2 North America Drug Discovery & Development Market by Country
    • 10.1.1.3 North America Agriculture & Animal Research Market by Country
    • 10.1.1.4 North America Personalized Medicine & Others Market by Country
  • 10.1.2 North America Nucleic Acid Isolation and Purification Market by Product
    • 10.1.2.1 North America Reagents Market by Country
    • 10.1.2.2 North America Kits Market by Country
    • 10.1.2.3 North America Instruments Market by Country
  • 10.1.3 North America Nucleic Acid Isolation and Purification Market by Method
    • 10.1.3.1 North America Magnetic Beads Market by Country
    • 10.1.3.2 North America Column Based Market by Country
    • 10.1.3.3 North America Reagent Based Market by Country
    • 10.1.3.4 North America Others Market by Country
  • 10.1.4 North America Nucleic Acid Isolation and Purification Market by Type
    • 10.1.4.1 North America Plasmid DNA Isolation & Purification Market by Country
    • 10.1.4.2 North America Total RNA Isolation & Purification Market by Country
    • 10.1.4.3 North America Circulating Nucleic Acid Isolation & Purification Market by Country
    • 10.1.4.4 North America Genomic DNA Isolation & Purification Market by Country
    • 10.1.4.5 North America Messenger RNA Isolation & Purification Market by Country
    • 10.1.4.6 North America microRNA Isolation & Purification Market by Country
    • 10.1.4.7 North America Others Market by Country
  • 10.1.5 North America Nucleic Acid Isolation and Purification Market by End User
    • 10.1.5.1 North America Hospitals & Diagnostic Centers Market by Country
    • 10.1.5.2 North America Pharmaceutical & Biotechnology Companies Market by Country
    • 10.1.5.3 North America Academic Research Institutes Market by Country
    • 10.1.5.4 North America Contract Research Organizations Market by Country
    • 10.1.5.5 North America Others Market by Country
  • 10.1.6 North America Nucleic Acid Isolation and Purification Market by Country
    • 10.1.6.1 US Nucleic Acid Isolation and Purification Market
      • 10.1.6.1.1 US Nucleic Acid Isolation and Purification Market by Application
      • 10.1.6.1.2 US Nucleic Acid Isolation and Purification Market by Product
      • 10.1.6.1.3 US Nucleic Acid Isolation and Purification Market by Method
      • 10.1.6.1.4 US Nucleic Acid Isolation and Purification Market by Type
      • 10.1.6.1.5 US Nucleic Acid Isolation and Purification Market by End User
    • 10.1.6.2 Canada Nucleic Acid Isolation and Purification Market
      • 10.1.6.2.1 Canada Nucleic Acid Isolation and Purification Market by Application
      • 10.1.6.2.2 Canada Nucleic Acid Isolation and Purification Market by Product
      • 10.1.6.2.3 Canada Nucleic Acid Isolation and Purification Market by Method
      • 10.1.6.2.4 Canada Nucleic Acid Isolation and Purification Market by Type
      • 10.1.6.2.5 Canada Nucleic Acid Isolation and Purification Market by End User
    • 10.1.6.3 Mexico Nucleic Acid Isolation and Purification Market
      • 10.1.6.3.1 Mexico Nucleic Acid Isolation and Purification Market by Application
      • 10.1.6.3.2 Mexico Nucleic Acid Isolation and Purification Market by Product
      • 10.1.6.3.3 Mexico Nucleic Acid Isolation and Purification Market by Method
      • 10.1.6.3.4 Mexico Nucleic Acid Isolation and Purification Market by Type
      • 10.1.6.3.5 Mexico Nucleic Acid Isolation and Purification Market by End User
    • 10.1.6.4 Rest of North America Nucleic Acid Isolation and Purification Market
      • 10.1.6.4.1 Rest of North America Nucleic Acid Isolation and Purification Market by Application
      • 10.1.6.4.2 Rest of North America Nucleic Acid Isolation and Purification Market by Product
      • 10.1.6.4.3 Rest of North America Nucleic Acid Isolation and Purification Market by Method
      • 10.1.6.4.4 Rest of North America Nucleic Acid Isolation and Purification Market by Type
      • 10.1.6.4.5 Rest of North America Nucleic Acid Isolation and Purification Market by End User
• 10.2 Europe Nucleic Acid Isolation and Purification Market
  • 10.2.1 Europe Nucleic Acid Isolation and Purification Market by Application
    • 10.2.1.1 Europe Diagnostics Market by Country
    • 10.2.1.2 Europe Drug Discovery & Development Market by Country
    • 10.2.1.3 Europe Agriculture & Animal Research Market by Country
    • 10.2.1.4 Europe Personalized Medicine & Others Market by Country
  • 10.2.2 Europe Nucleic Acid Isolation and Purification Market by Product
    • 10.2.2.1 Europe Reagents Market by Country
    • 10.2.2.2 Europe Kits Market by Country
    • 10.2.2.3 Europe Instruments Market by Country
  • 10.2.3 Europe Nucleic Acid Isolation and Purification Market by Method
    • 10.2.3.1 Europe Magnetic Beads Market by Country
    • 10.2.3.2 Europe Column Based Market by Country
    • 10.2.3.3 Europe Reagent Based Market by Country
    • 10.2.3.4 Europe Others Market by Country
  • 10.2.4 Europe Nucleic Acid Isolation and Purification Market by Type
    • 10.2.4.1 Europe Plasmid DNA Isolation & Purification Market by Country
    • 10.2.4.2 Europe Total RNA Isolation & Purification Market by Country
    • 10.2.4.3 Europe Circulating Nucleic Acid Isolation & Purification Market by Country
    • 10.2.4.4 Europe Genomic DNA Isolation & Purification Market by Country
    • 10.2.4.5 Europe Messenger RNA Isolation & Purification Market by Country
    • 10.2.4.6 Europe microRNA Isolation & Purification Market by Country
    • 10.2.4.7 Europe Others Market by Country
  • 10.2.5 Europe Nucleic Acid Isolation and Purification Market by End User
    • 10.2.5.1 Europe Hospitals & Diagnostic Centers Market by Country
    • 10.2.5.2 Europe Pharmaceutical & Biotechnology Companies Market by Country
    • 10.2.5.3 Europe Academic Research Institutes Market by Country
    • 10.2.5.4 Europe Contract Research Organizations Market by Country
    • 10.2.5.5 Europe Others Market by Country
  • 10.2.6 Europe Nucleic Acid Isolation and Purification Market by Country
    • 10.2.6.1 Germany Nucleic Acid Isolation and Purification Market
      • 10.2.6.1.1 Germany Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.1.2 Germany Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.1.3 Germany Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.1.4 Germany Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.1.5 Germany Nucleic Acid Isolation and Purification Market by End User
    • 10.2.6.2 UK Nucleic Acid Isolation and Purification Market
      • 10.2.6.2.1 UK Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.2.2 UK Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.2.3 UK Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.2.4 UK Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.2.5 UK Nucleic Acid Isolation and Purification Market by End User
    • 10.2.6.3 France Nucleic Acid Isolation and Purification Market
      • 10.2.6.3.1 France Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.3.2 France Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.3.3 France Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.3.4 France Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.3.5 France Nucleic Acid Isolation and Purification Market by End User
    • 10.2.6.4 Russia Nucleic Acid Isolation and Purification Market
      • 10.2.6.4.1 Russia Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.4.2 Russia Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.4.3 Russia Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.4.4 Russia Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.4.5 Russia Nucleic Acid Isolation and Purification Market by End User
    • 10.2.6.5 Spain Nucleic Acid Isolation and Purification Market
      • 10.2.6.5.1 Spain Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.5.2 Spain Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.5.3 Spain Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.5.4 Spain Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.5.5 Spain Nucleic Acid Isolation and Purification Market by End User
    • 10.2.6.6 Italy Nucleic Acid Isolation and Purification Market
      • 10.2.6.6.1 Italy Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.6.2 Italy Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.6.3 Italy Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.6.4 Italy Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.6.5 Italy Nucleic Acid Isolation and Purification Market by End User
    • 10.2.6.7 Rest of Europe Nucleic Acid Isolation and Purification Market
      • 10.2.6.7.1 Rest of Europe Nucleic Acid Isolation and Purification Market by Application
      • 10.2.6.7.2 Rest of Europe Nucleic Acid Isolation and Purification Market by Product
      • 10.2.6.7.3 Rest of Europe Nucleic Acid Isolation and Purification Market by Method
      • 10.2.6.7.4 Rest of Europe Nucleic Acid Isolation and Purification Market by Type
      • 10.2.6.7.5 Rest of Europe Nucleic Acid Isolation and Purification Market by End User
• 10.3 Asia Pacific Nucleic Acid Isolation and Purification Market
  • 10.3.1 Asia Pacific Nucleic Acid Isolation and Purification Market by Application
    • 10.3.1.1 Asia Pacific Diagnostics Market by Country
    • 10.3.1.2 Asia Pacific Drug Discovery & Development Market by Country
    • 10.3.1.3 Asia Pacific Agriculture & Animal Research Market by Country
    • 10.3.1.4 Asia Pacific Personalized Medicine & Others Market by Country
  • 10.3.2 Asia Pacific Nucleic Acid Isolation and Purification Market by Product
    • 10.3.2.1 Asia Pacific Reagents Market by Country
    • 10.3.2.2 Asia Pacific Kits Market by Country
    • 10.3.2.3 Asia Pacific Instruments Market by Country
  • 10.3.3 Asia Pacific Nucleic Acid Isolation and Purification Market by Method
    • 10.3.3.1 Asia Pacific Magnetic Beads Market by Country
    • 10.3.3.2 Asia Pacific Column Based Market by Country
    • 10.3.3.3 Asia Pacific Reagent Based Market by Country
    • 10.3.3.4 Asia Pacific Others Market by Country
  • 10.3.4 Asia Pacific Nucleic Acid Isolation and Purification Market by Type
    • 10.3.4.1 Asia Pacific Plasmid DNA Isolation & Purification Market by Country
    • 10.3.4.2 Asia Pacific Total RNA Isolation & Purification Market by Country
    • 10.3.4.3 Asia Pacific Circulating Nucleic Acid Isolation & Purification Market by Country
    • 10.3.4.4 Asia Pacific Genomic DNA Isolation & Purification Market by Country
    • 10.3.4.5 Asia Pacific Messenger RNA Isolation & Purification Market by Country
    • 10.3.4.6 Asia Pacific microRNA Isolation & Purification Market by Country
    • 10.3.4.7 Asia Pacific Others Market by Country
  • 10.3.5 Asia Pacific Nucleic Acid Isolation and Purification Market by End User
    • 10.3.5.1 Asia Pacific Hospitals & Diagnostic Centers Market by Country
    • 10.3.5.2 Asia Pacific Pharmaceutical & Biotechnology Companies Market by Country
    • 10.3.5.3 Asia Pacific Academic Research Institutes Market by Country
    • 10.3.5.4 Asia Pacific Contract Research Organizations Market by Country
    • 10.3.5.5 Asia Pacific Others Market by Country
  • 10.3.6 Asia Pacific Nucleic Acid Isolation and Purification Market by Country
    • 10.3.6.1 China Nucleic Acid Isolation and Purification Market
      • 10.3.6.1.1 China Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.1.2 China Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.1.3 China Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.1.4 China Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.1.5 China Nucleic Acid Isolation and Purification Market by End User
    • 10.3.6.2 Japan Nucleic Acid Isolation and Purification Market
      • 10.3.6.2.1 Japan Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.2.2 Japan Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.2.3 Japan Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.2.4 Japan Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.2.5 Japan Nucleic Acid Isolation and Purification Market by End User
    • 10.3.6.3 India Nucleic Acid Isolation and Purification Market
      • 10.3.6.3.1 India Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.3.2 India Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.3.3 India Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.3.4 India Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.3.5 India Nucleic Acid Isolation and Purification Market by End User
    • 10.3.6.4 South Korea Nucleic Acid Isolation and Purification Market
      • 10.3.6.4.1 South Korea Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.4.2 South Korea Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.4.3 South Korea Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.4.4 South Korea Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.4.5 South Korea Nucleic Acid Isolation and Purification Market by End User
    • 10.3.6.5 Singapore Nucleic Acid Isolation and Purification Market
      • 10.3.6.5.1 Singapore Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.5.2 Singapore Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.5.3 Singapore Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.5.4 Singapore Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.5.5 Singapore Nucleic Acid Isolation and Purification Market by End User
    • 10.3.6.6 Malaysia Nucleic Acid Isolation and Purification Market
      • 10.3.6.6.1 Malaysia Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.6.2 Malaysia Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.6.3 Malaysia Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.6.4 Malaysia Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.6.5 Malaysia Nucleic Acid Isolation and Purification Market by End User
    • 10.3.6.7 Rest of Asia Pacific Nucleic Acid Isolation and Purification Market
      • 10.3.6.7.1 Rest of Asia Pacific Nucleic Acid Isolation and Purification Market by Application
      • 10.3.6.7.2 Rest of Asia Pacific Nucleic Acid Isolation and Purification Market by Product
      • 10.3.6.7.3 Rest of Asia Pacific Nucleic Acid Isolation and Purification Market by Method
      • 10.3.6.7.4 Rest of Asia Pacific Nucleic Acid Isolation and Purification Market by Type
      • 10.3.6.7.5 Rest of Asia Pacific Nucleic Acid Isolation and Purification Market by End User
• 10.4 LAMEA Nucleic Acid Isolation and Purification Market
  • 10.4.1 LAMEA Nucleic Acid Isolation and Purification Market by Application
    • 10.4.1.1 LAMEA Diagnostics Market by Country
    • 10.4.1.2 LAMEA Drug Discovery & Development Market by Country
    • 10.4.1.3 LAMEA Agriculture & Animal Research Market by Country
    • 10.4.1.4 LAMEA Personalized Medicine & Others Market by Country
  • 10.4.2 LAMEA Nucleic Acid Isolation and Purification Market by Product
    • 10.4.2.1 LAMEA Reagents Market by Country
    • 10.4.2.2 LAMEA Kits Market by Country
    • 10.4.2.3 LAMEA Instruments Market by Country
  • 10.4.3 LAMEA Nucleic Acid Isolation and Purification Market by Method
    • 10.4.3.1 LAMEA Magnetic Beads Market by Country
    • 10.4.3.2 LAMEA Column Based Market by Country
    • 10.4.3.3 LAMEA Reagent Based Market by Country
    • 10.4.3.4 LAMEA Others Market by Country
  • 10.4.4 LAMEA Nucleic Acid Isolation and Purification Market by Type
    • 10.4.4.1 LAMEA Plasmid DNA Isolation & Purification Market by Country
    • 10.4.4.2 LAMEA Total RNA Isolation & Purification Market by Country
    • 10.4.4.3 LAMEA Circulating Nucleic Acid Isolation & Purification Market by Country
    • 10.4.4.4 LAMEA Genomic DNA Isolation & Purification Market by Country
    • 10.4.4.5 LAMEA Messenger RNA Isolation & Purification Market by Country
    • 10.4.4.6 LAMEA microRNA Isolation & Purification Market by Country
    • 10.4.4.7 LAMEA Others Market by Country
  • 10.4.5 LAMEA Nucleic Acid Isolation and Purification Market by End User
    • 10.4.5.1 LAMEA Hospitals & Diagnostic Centers Market by Country
    • 10.4.5.2 LAMEA Pharmaceutical & Biotechnology Companies Market by Country
    • 10.4.5.3 LAMEA Academic Research Institutes Market by Country
    • 10.4.5.4 LAMEA Contract Research Organizations Market by Country
    • 10.4.5.5 LAMEA Others Market by Country
  • 10.4.6 LAMEA Nucleic Acid Isolation and Purification Market by Country
    • 10.4.6.1 Brazil Nucleic Acid Isolation and Purification Market
      • 10.4.6.1.1 Brazil Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.1.2 Brazil Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.1.3 Brazil Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.1.4 Brazil Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.1.5 Brazil Nucleic Acid Isolation and Purification Market by End User
    • 10.4.6.2 Argentina Nucleic Acid Isolation and Purification Market
      • 10.4.6.2.1 Argentina Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.2.2 Argentina Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.2.3 Argentina Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.2.4 Argentina Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.2.5 Argentina Nucleic Acid Isolation and Purification Market by End User
    • 10.4.6.3 UAE Nucleic Acid Isolation and Purification Market
      • 10.4.6.3.1 UAE Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.3.2 UAE Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.3.3 UAE Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.3.4 UAE Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.3.5 UAE Nucleic Acid Isolation and Purification Market by End User
    • 10.4.6.4 Saudi Arabia Nucleic Acid Isolation and Purification Market
      • 10.4.6.4.1 Saudi Arabia Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.4.2 Saudi Arabia Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.4.3 Saudi Arabia Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.4.4 Saudi Arabia Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.4.5 Saudi Arabia Nucleic Acid Isolation and Purification Market by End User
    • 10.4.6.5 South Africa Nucleic Acid Isolation and Purification Market
      • 10.4.6.5.1 South Africa Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.5.2 South Africa Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.5.3 South Africa Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.5.4 South Africa Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.5.5 South Africa Nucleic Acid Isolation and Purification Market by End User
    • 10.4.6.6 Nigeria Nucleic Acid Isolation and Purification Market
      • 10.4.6.6.1 Nigeria Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.6.2 Nigeria Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.6.3 Nigeria Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.6.4 Nigeria Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.6.5 Nigeria Nucleic Acid Isolation and Purification Market by End User
    • 10.4.6.7 Rest of LAMEA Nucleic Acid Isolation and Purification Market
      • 10.4.6.7.1 Rest of LAMEA Nucleic Acid Isolation and Purification Market by Application
      • 10.4.6.7.2 Rest of LAMEA Nucleic Acid Isolation and Purification Market by Product
      • 10.4.6.7.3 Rest of LAMEA Nucleic Acid Isolation and Purification Market by Method
      • 10.4.6.7.4 Rest of LAMEA Nucleic Acid Isolation and Purification Market by Type
      • 10.4.6.7.5 Rest of LAMEA Nucleic Acid Isolation and Purification Market by End User

Chapter 11. Company Profiles

• 11.1 Thermo Fisher Scientific, Inc.
  • 11.1.1 Company Overview
  • 11.1.2 Financial Analysis
  • 11.1.3 Segmental and Regional Analysis
  • 11.1.4 Research & Development Expenses
  • 11.1.5 Recent strategies and developments:
    • 11.1.5.1 Partnerships, Collaborations, and Agreements:
    • 11.1.5.2 Product Launches and Product Expansions:
  • 11.1.6 SWOT Analysis
• 11.2 Qiagen N.V.
  • 11.2.1 Company Overview
  • 11.2.2 Financial Analysis
  • 11.2.3 Regional Analysis
  • 11.2.4 Research & Development Expense
  • 11.2.5 Recent strategies and developments:
    • 11.2.5.1 Product Launches and Product Expansions:
    • 11.2.5.2 Acquisition and Mergers:
    • 11.2.5.3 Geographical Expansions:
  • 11.2.6 SWOT Analysis
• 11.3 F. Hoffmann-La Roche Ltd.
  • 11.3.1 Company Overview
  • 11.3.2 Financial Analysis
  • 11.3.3 Segmental and Regional Analysis
  • 11.3.4 Research & Development Expense
  • 11.3.5 Recent strategies and developments:
    • 11.3.5.1 Partnerships, Collaborations, and Agreements:
    • 11.3.5.2 Product Launches and Product Expansions:
  • 11.3.6 SWOT Analysis
• 11.4 Merck KGaA
  • 11.4.1 Company Overview
  • 11.4.2 Financial Analysis
  • 11.4.3 Segmental and Regional Analysis
  • 11.4.4 Research & Development Expense
  • 11.4.5 SWOT Analysis
• 11.5 Promega Corporation
  • 11.5.1 Company Overview
  • 11.5.2 Recent strategies and developments:
    • 11.5.2.1 Partnerships, Collaborations, and Agreements:
    • 11.5.2.2 Product Launches and Product Expansions:
  • 11.5.3 SWOT Analysis
• 11.6 Agilent Technologies, Inc.
  • 11.6.1 Company Overview
  • 11.6.2 Financial Analysis
  • 11.6.3 Segmental and Regional Analysis
  • 11.6.4 Research & Development Expense
  • 11.6.5 SWOT Analysis
• 11.7 Danaher Corporation
  • 11.7.1 Company Overview
  • 11.7.2 Financial Analysis
  • 11.7.3 Segmental and Regional Analysis
  • 11.7.4 Research & Development Expense
  • 11.7.5 SWOT Analysis
• 11.8 Bio-Rad laboratories, Inc.
  • 11.8.1 Company Overview
  • 11.8.2 Financial Analysis
  • 11.8.3 Segmental and Regional Analysis
  • 11.8.4 Research & Development Expenses
  • 11.8.5 Recent strategies and developments:
    • 11.8.5.1 Product Launches and Product Expansions:
    • 11.8.5.2 Acquisition and Mergers:
  • 11.8.6 SWOT Analysis
• 11.9 Illumina, Inc.
  • 11.9.1 Company Overview
  • 11.9.2 Financial Analysis
  • 11.9.3 Regional Analysis
  • 11.9.4 Research & Development Expense
  • 11.9.5 SWOT Analysis
• 11.10. New England Biolabs, Inc.
  • 11.10.1 Company Overview
  • 11.10.2 SWOT Analysis

Chapter 12. Winning Strategies of Nucleic Acid Isolation and Purification Market